Business Context and Reporting Period
This Form 8-K Current Report was filed by Omeros Corporation on March 28, 2014. The report details a material modification to the rights of security holders regarding outstanding warrants.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. The document focuses exclusively on the terms of specific equity instruments.
- Warrant Quantity: 197,478 shares
- Exercise Price: $12.25 per share
- Original Issuance Date: March 29, 2007
- Original Expiration Date: March 29, 2014
Material Changes
Omeros extended the expiration date of the aforementioned warrants by six months. The new expiration date is September 29, 2014. These warrants were originally issued to brokers who assisted in the company's Series E Preferred Stock financing in 2007. This represents the third extension of these specific warrants, following previous extensions in 2012 and 2013.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies are discussed beyond the modification of the warrant terms. There are no unusual items reported in this document.
Investor Verification Checklist
- Verify the current market price of Omeros Common Stock relative to the $12.25 warrant exercise price to assess dilution potential.
- Confirm the total number of outstanding warrants and their impact on fully diluted share count.
- Review the original Series E Preferred Stock financing terms to understand the context of the broker warrants.
- Check for any subsequent filings regarding the exercise or expiration of these warrants after September 29, 2014.